CD32a polymorphism rs1801274 affects the risk of Kawasaki disease

References

• Leung AKC, Leong KF, Lam JM. Onychomadesis in a 20-month-old child with Kawasaki disease. Case Rep Pediatr. 2019;2019:3156736
   PubMed Web of Science ®Google Scholar
• Fernandez-Cooke E, Barrios Tascon A, Sanchez-Manubens J, et al. Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development (2011–2016): KAWA-RACE study group. PLoS One. 2019;14:e0215665.
   PubMed Web of Science ®Google Scholar
• Huang YH, Chen KD, Lo MH, et al. Decreased DNA methyltransferases expression is associated with coronary artery lesion formation in Kawasaki disease. Int J Med Sci. 2019;16:576–582.
   PubMed Web of Science ®Google Scholar
• Namita U, Saddiq MH, Ahamed Z. Simultaneous development of Kawasaki disease in identical twins: a case report. J Family Med Prim Care. 2019;8: 1481–1482.
   PubMedGoogle Scholar
• Goh YG, Ong CC, Tan G, et al. Coronary manifestations of Kawasaki Disease in computed tomography coronary angiography. J Cardiovasc Comput Tomogr. 2018;12:275–280.
   PubMed Web of Science ®Google Scholar
• Kuo HC. Preventing coronary artery lesions in Kawasaki disease. Biomed J. 2017;40:141–146.
   PubMed Web of Science ®Google Scholar
• Huang FC, Kuo HC, Huang YH, et al. Anti-inflammatory effect of resveratrol in human coronary arterial endothelial cells via induction of autophagy: implication for the treatment of Kawasaki disease. BMC Pharmacol Toxicol. 2017;18:3.
   PubMed Web of Science ®Google Scholar
• Lin MT, Wu MH. The global epidemiology of Kawasaki disease: review and future perspectives. Glob Cardiol Sci Pract. 2017;2017:e201720.
   PubMedGoogle Scholar
• Maggio MC, Cimaz R, Alaimo A, et al. Kawasaki disease triggered by parvovirus infection: an atypical case report of two siblings. J Med Case Rep. 2019;13:104
   PubMedGoogle Scholar
• Bournazos S, Ravetch JV. Fcγ receptor function and the design of vaccination strategies. Immunity. 2017;47:224–233.
   PubMed Web of Science ®Google Scholar
• Bruggeman CW, Dekkers G, Bentlage AEH, et al. Enhanced effector functions due to antibody defucosylation depend on the effector cell Fcgamma receptor profile. JI. 2017;199:204–211.
   Google Scholar
• Acevedo OA, Diaz FE, Beals TE, et al. Contribution of Fcgamma receptor-mediated immunity to the pathogenesis caused by the human respiratory syncytial virus. Front Cell Infect Microbiol. 2019;9:75.
   PubMed Web of Science ®Google Scholar
• Munde EO, Okeyo WA, Raballah E, et al. Association between Fcgamma receptor IIA, IIIA and IIIB genetic polymorphisms and susceptibility to severe malaria anemia in children in western Kenya. BMC Infect Dis. 2017;17:289.
   PubMed Web of Science ®Google Scholar
• Yagi H, Takakura D, Roumenina LT, et al. Site-specific N-glycosylation analysis of soluble Fcgamma receptor IIIb in human serum. Sci Rep. 2018;8:2719.
   PubMed Web of Science ®Google Scholar
• Chung S, Quarmby V, Gao X, et al. Quantitative evaluation of fucose reducing effects in a humanized antibody on Fcgamma receptor binding and antibody-dependent cell-mediated cytotoxicity activities. MAbs. 2012;4:326–340.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Yamanoi A, Machino Y, et al. Effect of trastuzumab interchain disulfide bond cleavage on Fcgamma receptor binding and antibody-dependent tumour cell phagocytosis. J Biochem. 2016;159:67–76.
   PubMed Web of Science ®Google Scholar
• Lu X, Peng S, Wang X, et al. Decreased expression of FcgammaRII in active Graves' disease patients. J Clin Lab Anal. 2019;33(6):e22904.
   PubMed Web of Science ®Google Scholar
• Arman M, Krauel K. Human platelet IgG Fc receptor FcgammaRIIA in immunity and thrombosis. J Thromb Haemost. 2015;13:893–908.
   PubMed Web of Science ®Google Scholar
• Onouchi Y, Ozaki K, Burns JC, et al. A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet. 2012;44:517–521.
   PubMed Web of Science ®Google Scholar
• Taniuchi S, Masuda M, Teraguchi M, et al. Polymorphism of Fc gamma RIIa may affect the efficacy of gamma-globulin therapy in Kawasaki disease. J Clin Immunol. 2005;25:309–313.
   PubMed Web of Science ®Google Scholar
• Biezeveld M, Geissler J, Merkus M, et al. The involvement of Fc gamma receptor gene polymorphisms in Kawasaki disease. Clin Exp Immunol. 2007;147:106–111.
   PubMed Web of Science ®Google Scholar
• Khor CC, Davila S, Breunis WB, et al. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet. 2011;43:1241–1246.
   PubMed Web of Science ®Google Scholar
• Ji YX, Zhang HY, Lin SX. Single nucleotide polymorphism of FCGR2A gene in Han Chinese children with Kawasaki disease. Zhongguo Dang Dai Er Ke Za Zhi 2013;15:196–200.
   PubMedGoogle Scholar
• Yan Y, Ma Y, Liu Y, et al. Combined analysis of genome-wide-linked susceptibility loci to Kawasaki disease in Han Chinese. Hum Genet. 2013;132:669–680.
   PubMed Web of Science ®Google Scholar
• Chatzikyriakidou A, Aidinidou L, Giannopoulos A, et al. Absence of association of FCGR2A gene polymorphism rs1801274 with Kawasaki disease in Greek patients. Cardiol Young. 2015;25:681–683.
   PubMed Web of Science ®Google Scholar
• Lou J, Zhong R, Shen N, et al. Systematic confirmation study of GWAS-identified genetic variants for Kawasaki disease in a Chinese population. Sci Rep. 2015;5:8194.
   PubMed Web of Science ®Google Scholar
• Nagelkerke SQ, Tacke CE, Breunis WB, et al. Extensive ethnic variation and linkage disequilibrium at the FCGR2/3 locus: different genetic associations revealed in Kawasaki disease. Front Immunol. 2019;10:185.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang BD, Liu YF, et al. Genetic susceptibility of ABCC4, FCGR2A and BLK polymorphisms with Kawasaki disease in children from southern China. Chinese J Lab Med. 2017;40:372–377.
   Google Scholar
• Kwon YC, Kim JJ, Yun SW, et al. Male-specific association of the FCGR2A His167Arg polymorphism with Kawasaki disease. PLoS One. 2017;12:e0184248.
   PubMed Web of Science ®Google Scholar
• Blackburn TE, Santiago T, Burrows PD. FCRLA-A resident endoplasmic reticulum protein that associates with multiple immunoglobulin isotypes in B lineage cells. Curr Top Microbiol Immunol. 2017;408:47–65.
   PubMed Web of Science ®Google Scholar
• Stein MM, Hrusch CL, Sperling AI, et al. Effects of an FcgammaRIIA polymorphism on leukocyte gene expression and cytokine responses to anti-CD3 and anti-CD28 antibodies. Genes Immun. 2019;20(6):462–472.
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang W, Zhang H, et al. Association of FCGR2A rs1801274 polymorphism with susceptibility to autoimmune diseases: a meta-analysis. Oncotarget. 2016;7:39436–39443.
   PubMedGoogle Scholar
• Li H, Jin Z, Li X, et al. Associations between single-nucleotide polymorphisms and inflammatory bowel disease-associated colorectal cancers in inflammatory bowel disease patients: a meta-analysis. Clin Transl Oncol. 2017;19:1018–1027.
   PubMed Web of Science ®Google Scholar
• Lee YH, Bae SC, Song GG. FCGR2A, FCGR3A, FCGR3B polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis. Clin Exp Rheumatol. 2015;33:647–654.
   PubMed Web of Science ®Google Scholar